Risk analysis for veterinary biologicals released into the environment.
All veterinary biologicals licensed in Canada must be shown to be pure, potent, safe and effective. A risk-based approach is used to evaluate the safety of all biologicals, whether produced by conventional methods or by molecular biological techniques. Traditionally, qualitative risk assessment methods have been used for this purpose. More recently, quantitative risk assessment has become available for complex issues. The quantitative risk assessment method uses "scenario tree analysis' to predict the likelihood of various outcomes and their respective impacts. The authors describe the quantitative risk assessment approach which is used within the broader context of risk analysis (i.e. risk assessment, risk management and risk communication) to develop recommendations for the field release of veterinary biologicals. The general regulatory framework for the licensing of veterinary biologicals in Canada is also presented.
Silva
S V
SV
Veterinary Biologics and Biotechnology Section, Agriculture and Agri-Food Canada, Nepean, Ontario, Canada.
Samagh
B S
BS
Morley
R S
RS
D000818:Animals; D001688:Biological Products / Q000592:standards*; D002170:Canada; D004787:Environmental Pollution / Q000517:prevention & control; D006801:Humans; D007880:Legislation, Drug; D007886:Legislation, Veterinary; D018570:Risk Assessment; D014612:Vaccines / Q000592:standards; D014730:Veterinary Medicine
D001688:Biological Products; D014612:Vaccines